Dr. Jeff Lombardo, PharmD, BCOP, Research Assistant Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
discusses chemotherapy compounding, related safety issues, and the advantages of INFUGEM™ (gemcitabine hydrochloride in 0.9% sodium chloride injection).
Related Items
Last modified: November 17, 2020